beta-hydroxy-beta-methylbutyrate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for beta-hydroxy-beta-methylbutyrate, covering 2023-09-22 to 2023-09-22. Get the full timeline:
Most recent: Clinical Trial Update: Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation [Phase 2]